More on Abbott Labs (ABT) Q3: net profit soars to $1.94B from $303M as operating margin soars to 20.4% from 6.1%. Total op costs -16%, with last year's SG&A expenses including $1.5B of litigation reserves. Abbot narrows FY EPS guidance to $5.06-$5.08 from $5-$5.10 previously and vs. consensus of $5.06. Says the separation into two companies is on track for Jan. 1.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.